Molecular and Cellular Biology, May 2006, p. 3810-3823, Vol. 26, No. 10
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.10.3810-3823.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity
Maggie C. Louie,
Alexey S. Revenko,
June X. Zou,
Jennifer Yao, and
Hong-Wu Chen*
Department of Biochemistry and Molecular Medicine, UCD Cancer Center/Basic Science, University of California at Davis, Sacramento, California 95817
Received 28 October 2005/
Returned for modification 30 November 2005/
Accepted 28 February 2006
ACTR (also called AIB1 and SRC-3) was identified as a coactivator for nuclear receptors and is linked to multiple types of human cancer due to its frequent overexpression. However, the molecular mechanism of ACTR oncogenicity and its function independent of nuclear receptors remain to be defined. We demonstrate here that ACTR is required for both normal and malignant human cells to effectively enter S phase. RNA interference-mediated depletion and chromatin immunoprecipitation assays show that endogenous ACTR directly controls the expression of genes important for initiation of DNA replication, which include cdc6, cdc25A, MCM7, cyclin E, and Cdk2. Moreover, consistent with its critical role in cell cycle control, ACTR expression appears to be cell cycle regulated, which involves E2F. Interestingly, ACTR is recruited to its own promoter at the G1/S transition and activates its own expression, suggesting a positive feedback mechanism for ACTR action in the control of cell cycle progression and for its aberrant expression in cancers. Importantly, overexpression of ACTR alone transforms human mammary epithelial cells, which requires its association with E2F. These findings reveal a novel role for ACTR in cell cycle control and support the notion that the ability of aberrant ACTR to deregulate the cell cycle through E2F underlies its oncogenicity in human cancers.
* Corresponding author. Mailing address: Department of Biochemistry and Molecular Medicine, UCD Cancer Center/Basic Science, University of California at Davis, Sacramento, CA 95817. Phone: (916) 734-7743. Fax: (916) 734-0190. E-mail: hwzchen{at}ucdavis.edu.
Molecular and Cellular Biology, May 2006, p. 3810-3823, Vol. 26, No. 10
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.10.3810-3823.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fereshteh, M. P., Tilli, M. T., Kim, S. E., Xu, J., O'Malley, B. W., Wellstein, A., Furth, P. A., Riegel, A. T.
(2008). The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice. Cancer Res.
68: 3697-3706
[Abstract]
[Full Text]
-
Zou, J. X., Revenko, A. S., Li, L. B., Gemo, A. T., Chen, H.-W.
(2007). ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ER{alpha}, is required for coregulator occupancy and chromatin modification. Proc. Natl. Acad. Sci. USA
104: 18067-18072
[Abstract]
[Full Text]
-
Chung, A. C-K., Zhou, S., Liao, L., Tien, J. C.-Y., Greenberg, N. M., Xu, J.
(2007). Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice. Cancer Res.
67: 5965-5975
[Abstract]
[Full Text]
-
Yan, J., Yu, C.-T., Ozen, M., Ittmann, M., Tsai, S. Y., Tsai, M.-J.
(2006). Steroid Receptor Coactivator-3 and Activator Protein-1 Coordinately Regulate the Transcription of Components of the Insulin-Like Growth Factor/AKT Signaling Pathway.. Cancer Res.
66: 11039-11046
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.